ProMIS Neurosciences to Participate in Upcoming Conferences in June
CAMBRIDGE, Mass. — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate…